新型类石墨烯二维纳米材料应用于肿瘤光声成像的研究进展

光声成像是一种新兴的非侵入式的生物成像方式,具有极高的空间分辨率和良好的成像对比度,已逐步应用于肿瘤成像诊断基础研究。光声成像主要依赖于光声信号转换,而光声信号转换能力主要取决于造影剂的选择。近年来,随着无机纳米材料在生物医学成像领域的研究逐渐深入,越来越多的二维无机纳米材料也应用于光声成像造影剂,尤其是新型类石墨烯二维纳米材料,其优异的近红外吸收率类似于石墨烯,光热转换效率高,生物相容性良好,而且部分材料还具备带隙可调特性以及良好的生物降解性,因此有望成为肿瘤光声成像理想的造影剂。其中,二维过渡金属硫化物、二维过渡金属碳/氮化物以及二维单元素材料已被多次报道应用于肿瘤光声成像造影剂的研发。该文将综述上述几类二维纳米材料在肿瘤光声成像诊断中的应用进展。     

一体化光声乳腺成像系统

本文报道了一种一体化光声乳腺成像系统,利用光纤束与柔性探测器相匹配形成一体化光声激发-耦合-探测,因此与传统的光声成像系统相比,该系统具有形态适应性的优势,并可以实现大视场的光声成像。本文通过样品实验和离体乳腺肿瘤成像实验,探究该系统的成像能力,证明该系统具有大规模临床乳腺肿瘤筛查的潜力。     

光声成像造影剂的研究进展

光声成像(PAT)是利用光声效应获得生物组织或材料的断层图像或三维立体图像的一种成像方法,它兼具光学和声学成像的优点,从而成为目前比较有应用前景的一种成像模式。光声成像造影剂是光声成像的对比增强剂,它通过改变局部组织的声学和光学特性,提高成像对比度和分辨率,从而显著增强光声成像的成像效果,成为当前生物医学领域研究的一个热点。目前常见的光声成像造影剂主要有金纳米材料,碳纳米材料,染料相关纳米材料以及其他纳米材料,这些材料有它们独特的优势,它们尺寸小,稳定性好,具有良好的生物相容性,但在临床应用时本身又存在一些问题。本文综述了光声成像造影剂的种类并简要概述了其研究进展,并对其未来在生物医学领域的应用前景做了进一步展望。     

基于直线电机连续-步进运动的快速光声显微成像系统

报道了一种利用直线电机连续-步进的扫描方式进行光声显微成像的系统,该系统在运动时走弓字型路线,其中直线电机在X轴方向上连续运动,在Y轴方向上以步进的方式运动,采集卡只在X轴电机运动的过程中连续采集。该成像系统较之前振镜扫描的方式扫描的范围更大,可达到厘米尺度范围内的生物组织光声成像;较之前的步进电机逐点扫描的方式扫描速度明显提高。同时本文采用电机带动光和超声换能器一同扫描的方式,较光和超声换能器不动电机带动样品扫描的方式更灵活。另外利用包埋碳丝的模拟样品和在体小鼠耳朵血管来验证系统的成像能力。实验结果表明,这种快速光声显微成像方法及其系统可以实现在体组织的高分辨率成像,有望成为一种无创、实时的光声显微镜应用于生物医学当中。     

生物组织光声粘弹显微成像

提出一种反演生物组织粘弹信息的新型无损光声粘弹显微成像方法,它是以强度调制激光作为激发源,通过检测光声（Photoacoustic,PA）信号的相位重建组织粘弹特性分布的成像方法.实验利用不同浓度的琼脂样品来验证光声粘弹显微测量中相位随浓度变化的依赖关系.利用埋有头发丝的琼脂样品来测试这种显微方法的成像分辨率.利用具有不同粘弹性的离体生物组织来验证系统的成像能力.实验结果表明,这种新方法能够高分辨率和高对比度地重建出具有不同粘弹性的生物组织的光声粘弹显微图像,有望实现组织结晶类病变水平的显微在体检测.     

利用散射光声微分成像技术实现弱吸收物质显微成像

光声显微成像技术依赖于样品的内源性光吸收,对强散射弱吸收样品成像效果差,甚至无法进行成像。为了实现强散射弱吸收高透明生物样品的光声显微成像,以及获得图像的边缘增强效果,使光声显微成像技术在实际的生物医学研究中更有应用价值,本文首次将散射光声技术引入到光声微分显微技术中,研制了新型的散射光声微分成像技术。该技术不仅可以获得强散射弱吸收高透明生物样品的散射光声显微图像,还可以获得对应的边缘清晰的散射光声微分图像,对在生物医学研究领域有重要的应用意义。     

全光学光声/OCT双模态成像系统及其应用

本文提出了一种新型的全光学光声/OCT双模态成像系统。该系统利用同一个低相干迈克尔逊干涉仪即可实现非接触式光声成像和OCT于一体,系统装置结构简单,可同时获取生物组织的吸收与散射结构信息。通过模拟实验证明了该双模态成像系统的可行性及成像能力,并对活体小鼠耳朵同时进行光声/OCT成像测试,实验结果表明非接触式光声/OCT双模态成像系统可以实现生物组织内的微血管及散射结构的高分辨率成像。进一步地,我们将光声/OCT双模态成像系统应用于基底细胞癌的检测中,获得了初步的研究结果,表明了该系统在皮肤肿瘤诊断中的具有潜在的应用价值。     

基于直线电机的大视场快速光声显微成像系统

光声成像技术是近年来发展的一种新型的无损医学成像技术,它是以脉冲激光作为激发源,以检测的声信号为信息载体,通过相应的图像重建算法重建组织内部结构和功能信息的成像方法。该方法结合了光学成像和声学成像的特点,可提供深层组织高分辨率和高对比度的组织层析图像,在生物医学临床诊断以及在体成像领域具有广泛的应用前景。目前光声成像的扫描方式主要有基于步进电机扫描方式和基于振镜的扫描方式,本文针对目前步进电机扫描速度慢(10 mm×10 mm;0.001帧/s),振镜扫描范围小(1 mm2)的不足,发展了基于直线电机扫描的大视场快速光声显微成像系统。同一条扫描线过程中直线电机速度最高可达200 mm/s。该技术采用逐线采集光声信号的方式,比逐点采集光声信号的步进电机快800倍。该系统对10 mm×10 mm全场扫描的扫描速度为0.8帧/s。最大可扫描视场范围可以达到50 mm×50 mm。大视场快速光声显微成像系统的发展将为生物医学提供新的成像工具。     

转铁蛋白导向脂质体核磁造影剂纳米粒子(TfNTR-LipNBD-Magnevist)——一种肿瘤靶向磁共振造影剂

造影剂辅助的核磁共振成像是目前肿瘤诊断的最好方法之一.但是由于核磁共振成像内在的低灵敏性以及造影剂的非特异性,导致肿瘤早期诊断较为困难.文章将一种新的肿瘤靶向核磁造影剂纳米粒子应用于早期肿瘤的影像诊断.这种新的肿瘤靶向核磁造影剂纳米粒子由配体转铁蛋白(Tf)、纳米水平的正电脂质体(Lip)载体和临床常用的造影剂Magnevist(TfNIR-LipNBD-Magnevist)三部分构成.另外转铁蛋白和脂质体粒子上,亦标记了荧光物质用于确定转铁蛋白-脂质体-造影剂纳米粒子的靶向性,以及肿瘤的光学影像诊断.在体外实验中,利用激光共聚焦显微镜和光学影像证明了靶向纳米粒子介导的细胞内吞和特异性结合.在裸鼠肿瘤模型中,造影剂纳米粒子TfNIR-LipNBD-Magnevist经尾静脉注入后,显著增强了肿瘤内信号与周围组织的对比度.由造影剂纳米粒子介导的肿瘤内信号显著强于单独Magnevist辅助的肿瘤内信号.同时,利用光学影像方法,在肿瘤内检测到特异的荧光信号.其结果进一步支持了转铁蛋白-脂质体-造影剂(TfNIR-LipNBD-Magnevist)纳米粒子的靶向性和肿瘤影像诊断的有效性.     

热声、光声双模态早期乳腺肿瘤成像系统

本文提出一种热声、光声双模态乳腺肿瘤检测成像系统。本装置中,脉冲微波和脉冲激光分别为热声、光声激发源,产生的热声、光声信号被同一个超声探测器、同一套数据采集装置接收,用同一种成像算法重建出图像。该系统可同时获取多种互补的诊断参数,提高检测早期乳腺肿瘤的准确率。     

Integrating photoacoustic microscopy with other imaging technologies for multimodal imaging

As a hybrid optical microscopic imaging technology, photoacoustic microscopy images the optical absorption contrasts and takes advantage of low acoustic scattering of biological tissues to achieve high-resolution anatomical and functional imaging. When combined with other imaging modalities, photoacoustic microscopy-based multimodal technologies can provide complementary contrast mechanisms to reveal complementary information of biological tissues. To achieve intrinsically and precisely registered images in a multimodal photoacoustic microscopy imaging system, either the ultrasonic transducer or the light source can be shared among the different imaging modalities. These technologies are the major focus of this minireview. It also covered the progress of the recently developed penta-modal photoacoustic microscopy imaging system featuring a novel dynamic focusing technique enabled by OCT contour scan.     

Multi-scale molecular photoacoustic tomography of gene expression

Photoacoustic tomography (PAT) is a molecular imaging technology. Unlike conventional reporter gene imaging, which is usually based on fluorescence, photoacoustic reporter gene imaging relies only on optical absorption. This work demonstrates several key merits of PAT using lacZ, one of the most widely used reporter genes in biology. We show that the expression of lacZ can be imaged by PAT as deep as 5.0 cm in biological tissue, with resolutions of ～1.0 mm and ～0.4 mm in the lateral and axial directions, respectively. We further demonstrate non-invasive, simultaneous imaging of a lacZ-expressing tumor and its surrounding microvasculature in vivo by dual-wavelength acoustic-resolution photoacoustic microscopy (AR-PAM), with a lateral resolution of 45 μm and an axial resolution of 15 μm. Finally, using optical-resolution photoacoustic microscopy (OR-PAM), we show intra-cellular localization of lacZ expression, with a lateral resolution of a fraction of a micron. These results suggest that PAT is a complementary tool to conventional optical fluorescence imaging of reporter genes for linking biological studies from the microscopic to the macroscopic scales.     

Photoacoustic Tomography of Human Hepatic Malignancies Using Intraoperative Indocyanine Green Fluorescence Imaging

Recently, fluorescence imaging following the preoperative intravenous injection of indocyanine green has been used in clinical settings to identify hepatic malignancies during surgery. The aim of this study was to evaluate the ability of photoacoustic tomography using indocyanine green as a contrast agent to produce representative fluorescence images of hepatic tumors by visualizing the spatial distribution of indocyanine green on ultrasonographic images. Indocyanine green (0.5 mg/kg, intravenous) was preoperatively administered to 9 patients undergoing hepatectomy. Intraoperatively, photoacoustic tomography was performed on the surface of the resected hepatic specimens (n = 10) under excitation with an 800 nm pulse laser. In 4 hepatocellular carcinoma nodules, photoacoustic imaging identified indocyanine green accumulation in the cancerous tissue. In contrast, in one hepatocellular carcinoma nodule and five adenocarcinoma foci (one intrahepatic cholangiocarcinoma and 4 colorectal liver metastases), photoacoustic imaging delineated indocyanine green accumulation not in the cancerous tissue but rather in the peri-cancerous hepatic parenchyma. Although photoacoustic tomography enabled to visualize spatial distribution of ICG on ultrasonographic images, which was consistent with fluorescence images on cut surfaces of the resected specimens, photoacoustic signals of ICG-containing tissues decreased approximately by 40% even at 4 mm depth from liver surfaces. Photoacoustic tomography using indocyanine green also failed to identify any hepatocellular carcinoma nodules from the body surface of model mice with non-alcoholic steatohepatitis. In conclusion, photoacoustic tomography has a potential to enhance cancer detectability and differential diagnosis by ultrasonographic examinations and intraoperative fluorescence imaging through visualization of stasis of bile-excreting imaging agents in and/or around hepatic tumors. However, further technical advances are needed to improve the visibility of photoacoustic signals emitted from deeply-located lesions.     

Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents

In this report, we present a breast imaging technique combining high‐resolution near‐infrared (NIR) light induced photoacoustic tomography (PAT) with NIR dye‐labeled amino‐terminal fragments of urokinase plasminogen activator receptor (uPAR) targeted magnetic iron oxide nanoparticles (NIR830‐ATF‐IONP) for breast cancer imaging using an orthotopic mouse mammary tumor model. We show that accumulation of the targeted nanoparticles in the tumor led to photoacoustic contrast enhancement due to the high absorption of iron oxide nanoparticles (IONP). NIR fluorescence images were used to validate specific delivery of NIR830‐ATF‐IONP to mouse mammary tumors. We found that systemic delivery of the targeted IONP produced 4‐ and 10‐fold enhancement in photoacoustic signals in the tumor, compared to the tumor of the mice that received non‐targeted IONP or control mice. The use of targeted nanoparticles allowed imaging of tumors located as deep as 3.1 cm beneath the normal tissues. Our study indicates the potential of the combination of photoacoustic tomography and receptor‐targeted NIR830‐ATF‐IONP as a clinical tool that can provide improved specificity and sensitivity for breast cancer detection. (© 2014 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)     

荧光标记技术在肿瘤模型研究中的应用

目的利用绿色荧光小鼠和红色荧光蛋白标记肿瘤细胞,建立荧光标记的小鼠肿瘤模型,并建立活体荧光成像和荧光显微镜成像在整体和细胞水平直接观察肿瘤的技术。方法将小鼠B16黑色素瘤细胞接种到绿色荧光蛋白转基因小鼠皮下,建立GFP小鼠肿瘤模型。以红色荧光蛋白作为标记基因导入小鼠黑色素瘤细胞B16细胞,建立稳定表达红色荧光蛋白的细胞株。将表达红色荧光蛋白B16细胞接种到绿色荧光转基因小鼠皮下,建立双荧光小鼠肿瘤模型。用荧光显微镜和活体荧光成像系统检测小鼠肿瘤的发生发展。结果分别建立了GFP小鼠肿瘤模型和双色荧光小鼠肿瘤模型。利用活体荧光影像仪可以观察双色荧光小鼠模型中受体绿色荧光组织和红色荧光移植肿瘤相互融合。利用荧光显微镜,可以观察到肿瘤内绿色荧光标记的来源于受体小鼠的血管和免疫细胞。经香菇多糖刺激的GFP小鼠肿瘤模型的移植瘤组织中,来源于受体小鼠绿色荧光标记的免疫细胞明显多于经生理盐水刺激的对照小鼠。结论利用绿色荧光小鼠和红色荧光RFP标记肿瘤细胞建立荧光标记的小鼠肿瘤模型,采用活体荧光成像仪和荧光显微镜可在整体和细胞水平直接观察肿瘤的生长以及肿瘤与宿主的相互作用。     

In vivo imaging of subcutaneous structures using functional photoacoustic microscopy

Functional photoacoustic microscopy (fPAM) is a hybrid technology that permits noninvasive imaging of the optical absorption contrast in subcutaneous biological tissues. fPAM uses a focused ultrasonic transducer to detect high-frequency photoacoustic (PA) signals. Volumetric images of biological tissues can be formed by two-dimensional raster scanning, and functional parameters can be further extracted from spectral measurements. fPAM is safe and applicable to animals as well as humans. This protocol provides guidelines for parameter selection, system alignment, imaging operation, laser safety and data processing for in vivo fPAM. It currently takes approximately 100 min to carry out this protocol, including approximately 50 min for data acquisition using a 10-Hz pulse-repetition-rate laser system. The data acquisition time, however, can be significantly reduced by using a laser system with a higher pulse repetition rate.     

Noninvasive photoacoustic and fluorescent tracking of optical dye labeled T cellular activities of diseased sites at new depth

The migration of immune cells is crucial to the immune response. Visualization of these processes has previously been limited because of the imaging depth. We developed a deep‐penetrating, sensitive and high‐resolution method to use fast photoacoustic tomography (PAT) to image the dynamic changes of T cells in lymph node and diseases at new depth (up to 9.5 mm). T cells labeled with NIR‐797‐isothiocyanate, an excellent near‐infrared photoacoustic and fluorescent agent, were intravenously injected to the mice. We used fluorescence imaging to determine the location of T cells roughly and photoacoustic imaging is used to observe T‐cell responses in diseased sites deeply and carefully. The dynamic changes of T cells in lymph node, acute disease (bacterial infection) and chronic disease (tumor) were observed noninvasively by photoacoustic and fluorescence imaging at different time points. T cells accumulated gradually and reached a maximum at 4 hours and declined afterwards in lymph node and bacterial infection site. At tumor model, T cells immigrated to the tumor with a maximum at 12 hours. Our study can not only provide a new observing method for immune activities tracking, but also enable continuous monitoring for therapeutic interventions.      

多尺度的光声显微镜用于癌细胞及实体瘤成像

多尺度显微成像系统(M-PAM)被发展,并被用于成像从癌细胞到实体肿瘤的多尺度生物结构.该装置由二维运动平台,扫描振镜,物镜,聚焦超声换能器组成,其横向分辨率达到3 μm.结果显示该系统可以对体外培养黑色素瘤细胞与体内的黑色素瘤进行无标记成像.基于具有靶向性的探针,M-PAM系统可以对体外培养的U87-MG肿瘤细胞以及体内U87-MG实体肿瘤进行成像.综上所述,M-PAM系统将是研究肿瘤的有力工具.